From BigGo Finance · BigGo Finance · · 1m 10s
TL;DR: Peptron Gets Phase 1 Approval for Monthly Obesity Drug
Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December.
Peptron received South Korea's Ministry of Food and Drug Safety approval for PT403, a once-monthly obesity treatment candidate, with first dose planned for December. Peptron secures South Korea's Phase 1 approval for once-monthly obesity drug PT403, targeting first dose in December. Peptron received approval from South Korea's Ministry of Food and Drug Safety for PT403, a once-monthly obesity treatment candidate.
- Peptron Wins Phase 1 Approval
- PT403 Uses SmartDepot Platform
- First Dose Targeted for December
- Trial at Chungnam National University Hospital
Read the story version — the same reporting as a swipeable deck of 6 cards.






